ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

LQDA Liquidia Corporation

12.525
-0.005 (-0.04%)
최종 업데이트: 03:46:53
15분 지연
기업명 주식 심볼 시장 주식 타입
Liquidia Corporation LQDA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.005 -0.04% 12.525 03:46:53
개장가 저가 고가 종가 전일 종가
12.35 12.35 12.875 12.53
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/04/202422:00GLOBELiquidia Corporation to Present at 23rd Annual Needham..
01/04/202419:00GLOBEUpdate on Favorable Legal and Regulatory Outcomes Clearing..
13/03/202419:00GLOBELiquidia Corporation Reports Full Year 2023 Financial..
06/03/202420:30GLOBELiquidia Corporation to Report Full Year 2023 Financial..
05/03/202409:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202420:30GLOBELiquidia Corporation Announces Poster Presentation at the..
25/01/202421:01EDGAR2Form 8-K - Current report
25/01/202420:00GLOBELiquidia Corporation Provides Update on New Drug Application..
23/01/202421:30EDGAR2Form 8-K - Current report
19/01/202421:01EDGAR2Form 8-K - Current report
19/01/202420:30GLOBELiquidia Corporation Announces Updates to Operations..
17/01/202407:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/01/202421:42EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/01/202406:15EDGAR2Form 8-K - Current report
08/01/202422:22GLOBELiquidia Corporation Files Response to United Therapeutics..
05/01/202420:45GLOBELiquidia Provides Update on Clinical Pipeline Targeting PAH..
05/01/202411:37EDGAR2Form 8-K - Current report
04/01/202423:10GLOBELiquidia Corporation Announces $100 Million in New..
04/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
02/01/202420:45GLOBELiquidia Corporation to Present at 42nd Annual J.P. Morgan..
29/12/202306:30EDGAR2Form S-3/A - Registration statement under Securities Act of..
23/12/202306:08EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202307:16EDGAR2Form 8-K - Current report
21/12/202306:56GLOBEU.S. Federal Circuit Affirms Earlier PTAB Decision to..
19/12/202310:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202306:02EDGAR2Form 8-K - Current report
13/12/202306:41EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
12/12/202322:44EDGAR2Form 8-K - Current report
12/12/202321:13GLOBELiquidia Announces Pricing of Public Offering of Common..
12/12/202321:04EDGAR2Form 8-K - Current report
06/12/202311:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202311:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:30EDGAR2Form 8-K - Current report
07/11/202321:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202320:36EDGAR2Form 8-K - Current report
07/11/202320:30GLOBELiquidia Corporation Reports Third Quarter 2023 Financial..
31/10/202319:30GLOBELiquidia Corporation to Report Third Quarter 2023 Financial..
02/10/202320:00GLOBEEmergent BioSolutions Names Two Pharmaceutical Industry..
26/09/202306:00EDGAR2Form 8-K - Current report
26/09/202305:09GLOBEFDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
07/09/202305:37EDGAR2Form 8-K - Current report
07/09/202305:30GLOBEUnited Therapeutics Corporation Files Lawsuit Alleging..
06/09/202309:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202309:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/08/202319:00EDGAR2Form 8-K - Current report
10/08/202319:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202319:00GLOBELiquidia Corporation Reports Second Quarter 2023 Financial..
10/08/202319:00EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock